Skip to content

Author

César Payán-Gómez

We have 3 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Redifferentiation therapy prior to radioiodine in refractory differentiated thyroid cancer: A systematic review and meta-analysis

Background: Radioiodine (RAI)-refractory differentiated thyroid cancer (DTC) has a poor prognosis. Constitutive MAPK activation, frequently driven by BRAF V600E or RAS alterations, suppresses thyroid-specific genes and sodium-iodide symporter expression. Short-course BRAF and/or MEK inhibition before RAI aims to restor...

C. E. Jiménez-Canizales, R. Parra-Medina, C. Payán-Gómez et al. · 0 citations
Open access Oct 2026

Molecular Reclassification of Diffuse Gliomas: A Feasibility Study of Clinical Features and Survival Outcomes in Colombia

The feasibility of applying the 2021 World Health Organization Classification of Tumors of the Central Nervous System (WHO CNS5) to adult diffuse gliomas in Colombia was evaluated, and female sex was associated with longer survival in unadjusted analysis.

Edgar G. Ordóñez-Rubiano, F. Rodríguez, Cristian F. Siabato-Vargas et al. · 0 citations
Open access Sep 2026

Co-expression of the Mammaglobin (SCGB2A2) Gene With hsa-miR-184 and hsa-miR-190b Indicates Its Possible Role in Oncogenic Pathways in Breast Cancer

A positive correlation among the expression of hsa-miR-184, hsa-miR-190b, and SCGB2A2 suggests that they may participate in shared biological pathways that govern critical cellular processes, such as membrane trafficking and cell signaling, which are frequently disrupted in cancer.

Juan Felipe Abella-Duque, L. López-Kleine, R. Parra-Medina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.